# US 2015/0148355 A1 · Transdermal silicone gel (silogel) compositions and methods of preparation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0148355 A1
- Document ID: US20150148355A1
- Status: Published application
- Kind: A1
- Application number: 14/551,644
- Filed: 2014-11-24
- Published: 2015-05-28
- Earliest claimed: 2013-11-26
- Assignees: Humco Holding Group, Inc.
- Applicants: Humco Holding Group, Inc.
- Inventors: John Olin Trimble
- Web page: https://patentgrep.com/patent/US20150148355A1

## CPC

- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/113: Multiple emulsions, e.g. oil-in-water-in-oil {(A61K9/0026 takes precedence)}
- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 31/195: having an amino group
- A61K 31/196: the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 31/445: Non condensed piperidines, e.g. piperocaine
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/24: containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A silicone gel (“silogel”) composition used to deliver pharmaceutical products transdermally as well as a method for producing the silogel composition, which may contain up to 80% additive ingredients. Preferred embodiments of the invention may include silogel compositions which provide high viscosity/no separation due to API. They are not temperature-sensitive, have no shear stress from the ointment mill/EMP, have no gumming up/stickiness, and no hardening.

## Claims

### Claim 1

A silicone gel composition comprising:
a hydrophilic silicone copolyol with a chain length of about 10 to about 19;
a lipophilic silicone copolyol with a chain length of about 12 to about 18;
a non-ionic oil-in-water (O/W) emulsifier agent with a hydrophile-lipophile balance (HLB) value from about 8 to about 18;
a non-ionic water-in-oil (W/O) emulsifier agent with a hydrophile-lipophile balance (HLB) value from about 1 to about 8;
an inorganic hydrocolloid with modified or unmodified, naturally occurring or synthetic sheet silicates;
an organic hydrocolloid with long-chain, straight or branched polysaccharides about 250 to about 2500 units in length that contain hydroxyl groups that can bond to water molecules; and
a biocompatible surfactant with phosphatidylcholine.

### Claim 2 (depends on 1)

The silicone gel composition of claim 1, wherein the hydrophilic silicone copolyol comprises polyoxyethylene (EO) groups, partial or complete substitution of EO with polyoxypropylene (PO), varying degree of modification of grafted polymers, or a mixture thereof.

### Claim 3 (depends on 1)

The silicone gel composition of claim 1, wherein said hydrophilic silicone copolyol is present in a concentration range from about 0.1 to about 4.0 weight percent.

### Claim 4 (depends on 1)

The silicone gel composition of claim 1, wherein the lipophilic silicone copolyol comprises alkyl chains compatible with hydrocarbon oils, or a mixture thereof.

### Claim 5 (depends on 1)

The silicone gel composition of claim 1, wherein said lipophilic silicone copolyol is present in a concentration range from about 0.1 to about 4.0 weight percent.

### Claim 6 (depends on 1)

The silicone gel composition of claim 1, wherein the non-ionic oil-in-water (O/W) emulsifier agent comprises a polyethoxylated emulsifier, a polypropoxylated emulsifier, or a mixture thereof.

### Claim 7 (depends on 1)

The silicone gel composition of claim 1, wherein said non-ionic oil-in-water (O/W) emulsifier agent is present in a concentration range from about 1.0 to about 20.0 weight percent.

### Claim 8 (depends on 1)

The silicone gel composition of claim 1, wherein the non-ionic water-in-oil (W/O) emulsifier agent comprises an ester of an alkanecarboxylic acid emulsifier, or a mixture thereof.

### Claim 9 (depends on 1)

The silicone gel composition of claim 1, wherein said non-ionic water-in-oil (W/O) emulsifier agent is present in a concentration range from about 1.0 to about 20.0 weight percent.

### Claim 10 (depends on 1)

The silicone gel composition of claim 1, wherein the inorganic hydrocolloid comprises a bentonite, a hectorite, a hydrotalcite, or a mixture thereof.

### Claim 11 (depends on 1)

The silicone gel composition of claim 1, wherein said inorganic hydrocolloid is present in a concentration range from about 0.1 to about 4.0 weight percent.

### Claim 12 (depends on 1)

The silicone gel composition of claim 1, wherein the organic hydrocolloid comprises a gum, a polymer, a starch, or a mixture thereof.

### Claim 13 (depends on 1)

The silicone gel composition of claim 1, wherein said organic hydrocolloid is present in a concentration range from about 0.1 to about 4.0 weight percent.

### Claim 14 (depends on 1)

The silicone gel composition of claim 1, wherein the biocompatible surfactant with phosphatidylcholine comprises a naturally occurring unsaturated lecithin.

### Claim 15 (depends on 1)

The silicone gel composition of claim 1, wherein said biocompatible surfactant with phosphatidylcholine is present in a concentration range from about 0.1 to about 5.0 weight percent.

### Claim 16 (depends on 1)

A method for producing a transdermal delivery system for therapeutic agents comprising:
dissolving active therapeutic agents in the silicone gel composition of claim 1.

### Claim 17 (depends on 1)

A method of dissolving an active drug into the silicone gel composition of claim 1 comprising:
using an electronic pestle and mortar to mix the active drug into the silicone gel composition.

### Claim 18

A silicone gel composition prepared by the method comprising:
mixing a non-ionic oil-in-water (O/W) emulsifier agent with a hydrophile-lipophile balance (HLB) value from about 8 to about 18 with a non-polar solvent to produce an oil phase;
mixing an inorganic hydrocolloid having modified or unmodified, naturally occurring or synthetic sheet silicates with water to produce an inorganic hydrocolloid phase;
mixing an organic hydrocolloid having long-chain, straight or branched polysaccharides about 250 to about 2500 units in length that contain hydroxyl groups that can bond to water molecules with a hydrophilic silicone copolyol having a chain length of about 10 to about 19 and with a non-ionic water-in-oil (W/O) emulsifier agent having a hydrophile-lipophile balance (HLB) value from about 1 to about 8 and with water to produce an organic hydrocolloid phase;
mixing one or more lipophilic silicone copolyols to produce a silicone emulsifier phase;
mixing the inorganic hydrocolloid phase with the organic hydrocolloid phase to produce a hydrocolloid phase;
mixing the hydrocolloid phase with the oil phase to produce a hydrocolloid oil phase;
mixing the silicone emulsifier phase with the hydrocolloid oil phase to produce an emulsified phase;
adding a biocompatible surfactant to the emulsified phase and mixing to produce a surfactant emulsified phase; and
adding one or more antimicrobial agents, one or more moisturizers, and silicone to the surfactant emulsified phase and mixing to produce the silicone gel composition.
